Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer
Open Access
- 11 May 2010
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 102 (10), 1495-1502
- https://doi.org/10.1038/sj.bjc.6605676
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 17 references indexed in Scilit:
- Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patientsBreast Cancer Research and Treatment, 2009
- Circulating tumour cell detection on its way to routine diagnostic implementation?European Journal Of Cancer, 2007
- Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch SystemClinical Cancer Research, 2007
- Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast CancerClinical Cancer Research, 2006
- Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall SurvivalClinical Cancer Research, 2006
- HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer PatientsClinical Cancer Research, 2006
- Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor MutationsJNCI Journal of the National Cancer Institute, 2005
- Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant DiseasesClinical Cancer Research, 2004
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Isolation by Size of Epithelial Tumor CellsThe American Journal of Pathology, 2000